BEAM
Beam TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
BEAM vs peer average
44/100
BEAM vs. peer average (D vs. D)
Grade spread
A 2 · D 6 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Amgen is only a broad biotechnology commercialization benchmark; its scale and marketed portfolio make direct valuation comparisons with clinical-stage Beam unreliable.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
BEAM
Beam Therapeutics
AMGN
Amgen
Grade
D
D
Momentum
37
93
Value
41
61
Sentiment
60
28
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs AMGN
BEAM / AMGN
Grade Position
Below peers
BEAM vs. peer average (D vs. D)
44/100
Momentum
37
AMGNValue
41
AMGNSentiment
60
BEAMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs BEAM
AMGN is the first peer returned for this comparison set.